By BY REBECCA ROBBINS from NYT The agency’s acting head said a review should look into whether any interactions between agency staff and the drug developer, Biogen, broke F.D.A. rules.Health https://ift.tt/3qZb1Uo
via
F.D.A. Requests Federal Investigation of Alzheimer’s Drug Approval
By BY REBECCA ROBBINS from NYT The agency’s acting head said a review should look into whether any interactions between agency staff and the drug developer, Biogen, broke F.D.A. rules.Health https://ift.tt/3qZb1Uo
via
0 comments:
Post a Comment